just got another boost.
Real-world data show Wegovy cuts risk of heart attack, stroke or death by 57% vs. Tirzepatide in obese patients with cardiovascular disease.
This is not just about weight loss – it’s about saving lives. Bullish.
just got another boost.
Real-world data show Wegovy cuts risk of heart attack, stroke or death by 57% vs. Tirzepatide in obese patients with cardiovascular disease.
This is not just about weight loss – it’s about saving lives. Bullish.